| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |